Patient-Reported Outcome Claims In Labeling Should Be Specific To Evidence
Executive Summary
Patient-reported outcome instruments that measure simple concepts are not adequate to support complex claims in labeling, FDA said
You may also be interested in...
FDA's Final PRO Guidance Grounds Policy With More Details
Issued in December, the final guidance explains "content validity," and advises sponsors to use target product profiles and to document that patient input informed PRO instrument development.
FDA's Final PRO Guidance Grounds Policy With More Details
FDA's final guidance on patient-reported outcomes measurements adds more detail and information on practical application to the draft guidance issued several years ago - in keeping with the comments made on the draft
FDA's Final PRO Guidance Grounds Policy With More Details
FDA's final guidance on patient-reported outcomes measurements adds more detail and information on practical application to the draft guidance issued several years ago - in keeping with the comments made on the draft